Lilly, Merck, Pfizer Agree to Share Pre-Competitive Genomics Data on Lung, Gastric Cancers in Asia
February 24, 2010
Lilly, Merck, Pfizer Agree to Share Pre-Competitive Genomics Data on Lung, Gastric Cancers in Asia
Through the formation of the Asian Cancer Research Group, Eli Lily, Merck, and Pfizer have also committed "to create one of the most extensive pharmacogenomic cancer databases known to date."
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- MedImmune Turns to NGS in Collaboration with Shanghai Chest Hospital to Study Lung Cancer
February 29, 2012 / Clinical Sequencing News - Studies Explore Genetics Behind Hepatitis B and C Virus-Associated Liver Cancers
May 29, 2012 / GenomeWeb Daily News - Merck Serono Survey Finds Limited Test Access, High Costs a Barrier to Personalized Rx Adoption in UK
May 2, 2012 / Pharmacogenomics Reporter - Pfizer, Roche Officials Share Lessons Learned from Rx/Dx Co-development of Xalkori and Zelboraf
February 29, 2012 / Pharmacogenomics Reporter - BGI and Asia Cancer Research Group Collaborate to Sequence Lung and Liver Tumors
February 22, 2012 / Clinical Sequencing News